About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | TX2® Low Profile TAA Endovascular Graft

TX2® Low Profile TAA Endovascular Graft

NCT01151020·33 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Cook Research Incorporated

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Descending thoracic aneurysm with diameter ≥ 5.0 cm
Descending thoracic aneurysm with a history of growth ≥ 0.5 cm per year
Descending thoracic degenerative or atherosclerotic ulcer ≥ 10 mm in depth and 20 mm in diameter

You may not be if

Less than 18 years of age
Life expectancy less than 2 years
Pregnant or breastfeeding or planning on becoming pregnant within 60 months
Unwilling to comply with the follow-up schedule
Inability or refusal to give informed consent
Less than 30 days beyond primary endpoint for other investigative drug or device study

The record

StatusCompleted

PhaseNo phase

Taking part110

StartedMar 2010

UpdatedJan 22, 2021

Conditions

Aortic Aneurysm Penetrating Ulcer Vascular Disease

Where33

Kaiser Permanente
San Francisco, California, United States
Washington Hospital Center
Washington D.C., District of Columbia, United States
University of South Florida
Tampa, Florida, United States